Logo

American Heart Association

  2
  0


Final ID: 4147784

Computational Fluid Dynamics is Key Predictors of Adverse Events in Single Ventricle Patients After the Fontan

Abstract Body (Do not enter title and authors here): Introduction: Single ventricle patients following Fontan surgery may experience significant adverse outcomes. Hemodynamic metrics derived from image-based computational fluid dynamics (CFD) analysis could potentially serve as predictors.

Hypothesis: CFD-based measures can prognosticate the consequences of Fontan surgery.

Methods: This study randomly selected 217 Fontan patients who presented for cardiac magnetic resonance (CMR) from 2004-present obtaining anatomy and flows in the cavae and pulmonary arteries to obtain CFD. Hemodynamic metrics were indexed power loss (iPL, unitless) and resistance to flow in the Fontan connection (RTCPC , in WU). Recorded adverse events (AEs) included death, transplantation, cardiac arrest, admission to the cardiac intensive care unit, pleural effusion, catheterization, pacemaker implantation, protein-losing enteropathy, plastic bronchitis, liver fibrosis and cirrhosis, heart failure, and sustained ventricular tachycardia (VT). Independent two-sample Student's t-tests or Mann-Whitney tests were conducted depending on the normality of the data. Statistical significance was set at p < 0.05.

Results: Age at initial CMR was 12.9 ± 8.2 years, with 37 patients undergoing a second CMR at 16.8 ± 8.1 years. Follow-up occurred 5.1 ± 2.6 years after the initial CMR. The number of patients who experienced an outcome is in Table 1. In the cross-sectional study (n = 217, Table 2), both iPL and RTCPC were significantly correlated with subsequent occurrence of AEs. Higher iPL was significantly associated with liver fibrosis (p = 0.027) and cirrhosis (p = 0.042) and showed a borderline statistical significance for death (p = 0.055). Higher RTCPC predicted liver cirrhosis (p = 0.043) and death (p = 0.045), with borderline significance for liver fibrosis (p = 0.058). The longitudinal study (n = 36, Table 3) demonstrated that changes in RTCPC predicted death (p = 0.029), while changes in iPL were borderline significant (p = 0.058). Additionally, changes in RTCPC were also significantly correlated with sustained VT.

Conclusion: CFD-derived hemodynamics from CMR demonstrated promise as an important predictor of adverse events in single ventricle patients after Fontan. A larger prospective trial is warranted.
  • Wei, Zhenglun  ( Worcester Polytechnic Institute , Worcester , Massachusetts , United States )
  • Salargarna, Fatemeh  ( Worcester Polytechnic Institute , Worcester , Massachusetts , United States )
  • Murawsky, Jessica  ( CHILDRENS HOSPITAL OF PHILADELPHIA , Philadelphia , Pennsylvania , United States )
  • Si, Biao  ( Worcester Polytechnic Institute , Worcester , Massachusetts , United States )
  • Frechette, Joshua  ( Worcester Polytechnic Institute , Worcester , Massachusetts , United States )
  • Carter, Allen  ( Worcester Polytechnic Institute , Worcester , Massachusetts , United States )
  • Zou, Jian  ( Worcester Polytechnic Institute , Worcester , Massachusetts , United States )
  • Yoganathan, Ajit  ( GEORGIA INSTITUTE OF TECHNOLOGY , Atlanta , Georgia , United States )
  • Fogel, Mark  ( CHILDRENS HOSPITAL OF PHILADELPHIA , Philadelphia , Pennsylvania , United States )
  • Author Disclosures:
    Zhenglun Wei: DO have relevant financial relationships ; Consultant:Foldax Inc:Past (completed) ; Consultant:MedLumix S.L.:Past (completed) ; Consultant:WZ Biotech LLC:Past (completed) | Fatemeh Salargarna: DO NOT have relevant financial relationships | Jessica Murawsky: DO NOT have relevant financial relationships | Biao Si: No Answer | Joshua Frechette: No Answer | Allen Carter: No Answer | Jian Zou: DO NOT have relevant financial relationships | Ajit Yoganathan: No Answer | Mark Fogel: DO have relevant financial relationships ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Researcher:FARA:Past (completed) ; Consultant:Rocket Pharma:Past (completed) ; Research Funding (PI or named investigator):CMP Pharma:Active (exists now) ; Consultant:law firm:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Helen B. Taussig Memorial Lecture and Abstract Presentations

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Abstract Oral Session

More abstracts on this topic:
30-day and one-year outcomes of patients with severe aortic stenosis after TAVI using Myval : A Meta-analysis

Hasabo Elfatih A., Sultan Sherif, Soliman Osama, A. Aboali Amira, Hemmeda Lina, Salah Alaa, Alrawa Salma S., Elgadi Ammar, Abdalmotalib Malaz, Yasir H Eissa Abdullatif, Mahmmoud Fadelallah Eljack Mohammed

Abnormal Liver Stiffness as a Risk Factor for Elevated Hemoglobin A1c in Patients with Fontan Physiology

Tumuluru Priya, Lockhart Elli, Carr Michael, Kriegermeier Alyssa, Laternser Christina, Patel Sheetal

More abstracts from these authors:
Total and Regional Lung Volumes And Pulmonary Blood Flow In Repaired Tetralogy Of Fallot - Smaller Lungs And A Maldistribution of Flow

Fogel Mark, Whitehead Kevin, Biko David, Harris Matthew, Vaiyani Danish, Partington Sara, Mercer-rosa Laura

Effects of Angiotensin Converting Enzyme Inhibition And Afterload Reduction in Single Ventricle Patients Prior To Fontan: Not What You Might Think

Fogel Mark, Biko David, Giner Cassie, Jones Andrea, Ramirez Suarez Karen, Medina Maria, Partington Sara, Vaiyani Danish, Harris Matthew, Whitehead Kevin

You have to be authorized to contact abstract author. Please, Login
Not Available